Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Xoma issued further U.S. patents based on BPI platform

Aug. 1, 1997

Cel-Sci allowed patent for immune system technology

Aug. 1, 1997

Vyrex awarded U.S. patent for CD-Tagging

Aug. 1, 1997

Jenner licenses emulsion formulation from Walter Reed

July 29, 1997

RPR prepares novel transfection agents

July 29, 1997

Abgenix and Neugenesis collaborate on monoclonal antibody production

July 28, 1997

Oncogene Science and Hoechst Marion Roussel extend collaboration

July 28, 1997

Oxford BioMedica receives grant for the development of anticancer technology

July 28, 1997

Tularik and Roche Bioscience collaborate on antiinflammatory drug discovery

July 25, 1997

Vyrex establishes proof of principle for CD-Tagging in human cells

July 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...